Irinotecan Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — Ingenus Pharmaceuticals LLC

The FDA lists a drug shortage record for Irinotecan Hydrochloride Injection (injection) from Ingenus Pharmaceuticals LLC with status To Be Discontinued. The shortage was first posted on Feb 24, 2026.

Shortage details

Status
To Be Discontinued
Company
Ingenus Pharmaceuticals LLC
Package NDC
50742-401-02
Dosage Form
Injection
Presentation
Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02)
Initial Posting
Feb 24, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.